null
Loading... Please wait...
FREE SHIPPING on All Unbranded Items LEARN MORE
Print This Page

The Hunger Game (The Inside Story of GLP-1s and the Race to Cure Obesity)

List Price: $20.00
SKU:
9781250389084
Quantity:
Minimum Purchase
25 unit(s)
Expected release date is Jan 5th 2027
  • Availability: Confirm prior to ordering
  • Branding: minimum 50 pieces (add’l costs below)
  • Check Freight Rates (branded products only)

Branding Options (v), Availability & Lead Times

  • 1-Color Imprint: $2.00 ea.
  • Promo-Page Insert: $2.50 ea. (full-color printed, single-sided page)
  • Belly-Band Wrap: $2.50 ea. (full-color printed)
  • Set-Up Charge: $45 per decoration
FULL DETAILS
  • Availability: Product availability changes daily, so please confirm your quantity is available prior to placing an order.
  • Branded Products: allow 10 business days from proof approval for production. Branding options may be limited or unavailable based on product design or cover artwork.
  • Unbranded Products: allow 3-5 business days for shipping. All Unbranded items receive FREE ground shipping in the US. Inquire for international shipping.
  • RETURNS/CANCELLATIONS: All orders, branded or unbranded, are NON-CANCELLABLE and NON-RETURNABLE once a purchase order has been received.
  • Product Details

    Author:
    Aimee Donnellan
    Format:
    Paperback
    Pages:
    336
    Publisher:
    St. Martin's Publishing Group (January 5, 2027)
    Imprint:
    St. Martin's Griffin
    Release Date:
    January 5, 2027
    Language:
    English
    Audience:
    General/trade
    ISBN-13:
    9781250389084
    ISBN-10:
    1250389089
    Weight:
    16oz
    Dimensions:
    5.38" x 8.25" x 1"
    File:
    Macmillan Trade-Macmillan_Print_US_Trade_20260518220405-20260518.xml
    Folder:
    Macmillan Trade
    List Price:
    $20.00
    Pub Discount:
    65
    Case Pack:
    24
    As low as:
    $15.40
    Publisher Identifier:
    P-STM
    Discount Code:
    A
    QuickShip:
    Yes
  • Overview

    The inside story of the creation of Ozempic and its revolutionary impact on public health.

    A “cure” for obesity has long been the holy grail for the pharmaceutical industry, one that seemed unattainable until recent breakthroughs in type 2 diabetes research led to the development of Ozempic, a weight loss medication that activates a hormone in the stomach called GLP-1, making people feel fuller for longer. The treatment is so effective that it is already disrupting many industries—from healthcare to fast food to fashion—and it has quickly made its creator, Denmark’s Novo Nordisk, the most valuable company in Europe. But the impact of GLP-1s goes far beyond billion-dollar profits; a true long-term cure for obesity could save 40 percent of American adults from dangerous, preventable illnesses. And as more potential benefits emerge, one question looms in the minds of investors, healthcare workers, and politicians: Are these drugs too good to be true?

    In Off the Scales, Reuters journalist Aimee Donnellan illuminates the history of a medical breakthrough that is poised to change the world, while raising difficult social questions about inequality and morality. Through original reporting and rigorous research, she forecasts the future of GLP-1s and examines what their explosive popularity tells us about our ideals of beauty and the lengths to which people will go in order to become thin.

    Along the way, Donnellan profiles the scientist whose contributions to the discovery of GLP-1 were overlooked, documents her fight for recognition while her colleagues were thrust into the limelight, and offers new insights into the ways that the food and beauty industries made billions while promoting unhealthy and unrealistic body image standards and accelerating the obesity crisis. She also provides firsthand accounts of several early Ozempic users and the transformative effect the drug has had on their weight loss journeys.

    Off the Scales is an informative and entertaining study of the unexpected consequences of finally getting what we’ve wanted for so long.